Takeda

Few pharmaceuticals players in Asia Pacific match the executional depth of Takeda. From Tokyo, the group manages a workforce of approximately 49k and generates close to $30B in revenue, while steadily widening the gap with regional peers.

Long-term partnerships with sovereign and institutional investors give the company unusual visibility on multi-year demand.

“Takeda is, in its category, exactly the kind of compounding regional champion the next decade of capital allocation will reward.”

Few catalysts on the horizon look bearish; the central scenario is a continued, controlled compounding story.